<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="67421">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02228135</url>
  </required_header>
  <id_info>
    <org_study_id>IRB14-00588</org_study_id>
    <nct_id>NCT02228135</nct_id>
  </id_info>
  <brief_title>The Effect of Dexamethasone Dosing on Post-tonsillectomy Hemorrhage</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nicole Elsey</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nationwide Children's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a retrospective chart review looking at the effect of dexamethasone dosing on
      post-tonsillectomy hemorrhage.
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date>September 2014</start_date>
  <completion_date type="Anticipated">June 2017</completion_date>
  <primary_completion_date type="Anticipated">June 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Dexamethasone Dosage</measure>
    <time_frame>once at start of surgery</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">8700</enrollment>
  <condition>Tonsillectomy</condition>
  <condition>Adenotonsillectomy</condition>
  <arm_group>
    <arm_group_label>Non post-tonsillectomy hemorrhage</arm_group_label>
    <description>Children who do not have post-tonsillectomy hemorrhage.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Post-tonsillectomy hemorrhage</arm_group_label>
    <description>Children return to the hospital after surgery with post-tonsillectomy hemorrhage.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone</intervention_name>
    <arm_group_label>Non post-tonsillectomy hemorrhage</arm_group_label>
    <arm_group_label>Post-tonsillectomy hemorrhage</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Children who have had tonsillectomy or adenotonsillectomy
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing a tonsillectomy

          -  Patients undergoing an adenotonsillectomy

        Exclusion Criteria:

          -  All patients with a known history of bleeding or clotting disorders, as well as those
             patients who had presented to Nationwide Children's Hospital main operating room for
             control of PTH but had their initial tonsillectomy/adenotonsillectomy at an outlying
             facility will be excluded from the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Nationwide Children's Hospital</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <lastchanged_date>November 7, 2016</lastchanged_date>
  <firstreceived_date>August 27, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Nationwide Children's Hospital</investigator_affiliation>
    <investigator_full_name>Nicole Elsey</investigator_full_name>
    <investigator_title>Clinical Assistant Professor</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Dexamethasone 21-phosphate</mesh_term>
    <mesh_term>BB 1101</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
